Client News

Rentschler Biopharma and Coriolis Pharma announce strategic collaboration for integrated biopharma solutions

Tacalyx Appoints Jean Engela as Chief Executive Officer to Spearhead Next Phase of Growth

CARBIOS and Wankai New Materials sign the definitive agreement establishing a strategic partnership to the large-scale deployment of CARBIOS’s PET biorecycling technology in Asia

AFYREN raises €23 million through share capital increase to finance optimization and expansion of unique biorefinery AFYREN NEOXY

CARBIOS signs two new multi-year commercial agreements for recycled PET with major players in the beverage industry

Heidelberg Pharma Announces Changes to the Executive Management Board – Dr Dongzhou Jeffery Liu Appointed as Chairman of the Executive Board and Chief Executive Officer

MIG Capital, via its MIG Fonds, Leads €16 Million Seed Financing for AI Hardware Startup NcodiN

Mainz Biomed and OncoVanguard8 Enter into Agreement to bring ColoAlert to South America

Milestone achieved with FYB208: Biosimilar candidate for Dupixent® (dupilumab) as another growth driver in Formycon’s portfolio

Formycon publishes nine-month results and confirms guidance – Pipeline progress and strong partnerships drive fiscal year 2025